Pall T. Onundarson: The Fiix Test Team Was Awarded UNIVANTS 2025!
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, proudly reposted from Eduardo Freggiaro on LinkedIn:
”The Fiix test team was awarded UNIVANTS 2025 Team of Distinction and got to meet the UNIVANTS of HealthCare Excellence executives at the ADLM (previously AACC) 2025 in Chicago.
The prize is awarded by 7 important healthcare associations around the world.
These people see the potential of improved patient care through replacing the conventional monitoring method of warfarin and VKAs (PT-INR) with a new test that more accurately reflects the antithrombotic effect, reduces anticoagulation variability and enhances effectiveness of anticoagulation with the old drug class that everybody had written off and thought they knew all about…
But now clinical pharmacology needs some revision.
Fortunately, it is very easy to replace the PT-INR with the Fiix-NR: same instruments, same staff, mostly the same dosing protocols.
The Fiix test is CE marked in Europe, still for scientific use elsewhere, manufactured by Hart Biologicals Limited in England.”
Eduardo Freggiaro, President of FBA, Executive Board member of IFCC, shared an honoring post on LinkedIn:
”During the ADLM congress in Chicago I had the opportunity and honor to participate in this photo with the winners of the highest recognition of the UNIVANTS 2025 award.
Also present were previous winners, Abbott executives and the CEO of the ADLM.
Congratulations to Professor Pall T. Onundarson, M.D. and his team for the excellent work they have done.”
Stay updated on the emerging with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia